Sterne JA, Savovi J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al
Patent expiries of blockbuster weight loss GLP-1 (glucagon-like peptide-1) drugs are opening up a sizeable near-term opportunity for Indian pharmaceutical companies in regulated markets, led by Canada and Brazil, with a potential generic market value of about $500 million, according to Vishal Manchanda, Pharma Analyst at Systematix Group
However, the potential for side effects and interactions with other medications, such as semaglutide, highlights the need for careful consideration and monitoring
Astaxanthin is a Keto-carotenoid that significantly decreases ROS (a damaging molecule) production and has positive effects on male fertility by increasing sperm concentration and linear speed
Specifically, semaglutide (used in Ozempic and Wegovy) was removed from the drug shortage list on February 21, 2025, and tirzepatide (found in Mounjaro and Zepbound) was also taken off in late 2024
The following is a breakdown of the primary respondents: To know about the assumptions considered for the study, download the pdf brochure Market Size Estimation Both top-down and bottom-up approaches were used to estimate and validate the total size of the GLP-1 agonists market
.webp)
